EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Implications of High Melioidosis Serology Indirect Haemagglutination Assay Titre: A 20-Year Retrospective Study from the Top End of the Northern Territory, Australia

Cassandra Ho, Kevin Freeman, Celeste Woerle, Mila Mahoney, Mark Mayo, Robert W Baird, Ella M Meumann iD, Bart J Currie iD

Pathogens · 2025

DOI: 10.3390/pathogens14020165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Cassandra Ho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT 0811, Australia. Hauptthemen laut MEDLINE: Melioidosis, Burkholderia pseudomallei, Hemagglutination Tests, Antibodies, Bacterial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melioidosis, an infection with the bacterium Burkholderia pseudomallei, is highly endemic in the Top End of the Northern Territory of Australia. The indirect haemagglutination assay (IHA) is the most widely used serology test globally, but it is not standardised among the limited number of laboratories that perform it. While concerns have been raised about the sensitivity of IHA early in melioidosis infections, the advantage of IHA over more recently developed ELISAs is that testing serial dilutions allows a titre to be recorded. While in Australia a titre of 1:40 or higher is considered positive, the specificity at these low positive titres remains uncertain. However, a high titre is considered to represent recent or past true infection with B. pseudomallei, rather than cross-rection with other environmental Burkholderia species. Also, the natural history of IHA titres over time, in both asymptomatic infection and melioidosis has been little studied. We have assessed the clinical status and serology time courses of all 534 patients who had an IHA titre of 1:640 or higher, over a 20-year period. Of these, 324 (60.7%) were diagnosed with culture-confirmed melioidosis, with varying time courses of diagnosis of melioidosis in relation to the high serology. Of the 210 without confirmed melioidosis, 22 (10.5%) were considered highly likely to be melioidosis despite being culture-negative, and these were all treated as melioidosis. In the remainder, titres mostly gradually decreased over time, but the majority remained seropositive. A small number who had not been treated for melioidosis continued to have high IHA titres over years and activation from latency with a new diagnosis of melioidosis was occasionally documented. This study highlights the importance of a full clinical workup in those found to have high titre melioidosis serology as well as subsequent close clinical surveillance and where resources allow, yearly IHA in those not confirmed or treated as melioidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelioidosisBurkholderia pseudomalleiHemagglutination TestsAntibodies, BacterialHumansNorthern TerritoryRetrospective StudiesFemaleMaleMiddle AgedAdultAgedSensitivity and SpecificityYoung Adult

Stichwörter der Autor:innen

Burkholderia pseudomalleiindirect haemagglutination assaylatencymelioidosisneglected tropical diseaseserology

Substanzen

Antibodies, Bacterial

Autor:innen und Institutionen

  • Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT 0811, Australia.
  • Northern Territory Medical Program, Flinders University, Darwin, NT 0811, Australia.
  • Territory Pathology, Royal Darwin Hospital, Darwin, NT 0811, Australia.
  • Department of Infectious Diseases, Royal Darwin Hospital, Darwin, NT 0811, Australia.

ORCID-Profile: Ella M Meumann, Bart J Currie

Zitieren

APA

Ho, C., Freeman, K., Woerle, C., Mahoney, M., Mayo, M., Baird, R. W., Meumann, E. M., & Currie, B. J. (2025). Clinical Implications of High Melioidosis Serology Indirect Haemagglutination Assay Titre: A 20-Year Retrospective Study from the Top End of the Northern Territory, Australia. Pathogens. https://doi.org/10.3390/pathogens14020165

Vancouver

Ho C, Freeman K, Woerle C, Mahoney M, Mayo M, Baird RW, et al. Clinical Implications of High Melioidosis Serology Indirect Haemagglutination Assay Titre: A 20-Year Retrospective Study from the Top End of the Northern Territory, Australia. Pathogens. 2025. doi:10.3390/pathogens14020165

BibTeX
@article{Ho2025,
  author = {Ho, Cassandra and Freeman, Kevin and Woerle, Celeste and Mahoney, Mila and Mayo, Mark and Baird, Robert W and Meumann, Ella M and Currie, Bart J},
  title = {Clinical Implications of High Melioidosis Serology Indirect Haemagglutination Assay Titre: A 20-Year Retrospective Study from the Top End of the Northern Territory, Australia},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14020165}
}
Kostenlos starten →